FDA-approved products containing semaglutide and tirzepatide are available and may be more appropriate depending on individual patient needs and provider determination
Figures below reflect published pharmacokinetic data as of July 2026
Common Research Mixes: With GHRH analogs: Examining growth hormone axis effects With SARMs: Studying multiple anabolic pathways With other peptides: Studying paired mechanisms Factors: Adjust personal doses, track for interactions Documentation and Record Keeping Full records, including a certificate of analysis for each batch, is essential for research quality and reproducibility
Our full guide to Medicare Advantage Plans in Washington State walks through how to evaluate these tradeoffs county by county
But GLP-1 medications are not FDA-approved for this use, and the research is still developing
3 Armed Forces Hospital, Al Hada, Taif, Saudi Arabia